Flahy is the clinical intelligence layer for personalized complex care — integrating genetics, biomarkers, and clinical data into real-time treatment decisions.
Biology is becoming digitized — genetics, biomarkers, imaging, and longitudinal signals are increasingly available. Flahy’s agentic clinical system helps clinical workflows synthesize these inputs fast, consistently, and safely — unifying biology and clinical context to support:
Protocol Standardization
Ensuring the biological factors that matter are consistently considered.
Personalized Treatment
Connecting multi-modal clinical evidence into actionable next steps.
Flahy’s agentic clinical system is complemented by a portfolio of genetics-based preventive and precision medicine products — spanning foundational medicine, mental health, neurology, and oncology:
FlahyLife (Foundational Medicine)
A non-invasive saliva test with 1450+ health screenings to reveal susceptibilities and guide personalized prevention, supported by FlahyAI and a Drug Passport for safe & effective care when needed. (flahyhealth.com ↗︎)
FlahyClarity (Mental Health)
A non-invasive assessment that supports more personalized medication pathways and recovery planning in psychiatry, paired with genetics-powered guidance for daily lifestyle decisions. (flahyhealth.com ↗︎)
FlahyNeuro (Neurology)
A non-invasive assessment designed to improve medication fit and tolerability in neurology, translating genetic signals and biomarkers into practical, clinician-guided next steps. (flahyhealth.com ↗︎)
FlahyRecovery (Oncology)
A comprehensive precision oncology test that includes our proprietary biomarker to predict immuno-oncology (IO) response, inform combination therapy design, and clinical trial matching. (flahyhealth.com ↗︎)
Leadership
Jagjit Singh
Founder & Chief Executive Officer
Advisory Board
Christopher Mason
Raul Rabadan
Andrew Blumberg
Kaja Wasik
Arun Goyal